Taking it to the street
Results 1 - 10 of 308 : 1 2 3 4 5 6 7 8 9 Next
Get RSS Feed for Serial Acquirer
3 of the Dow's biggest headline-makers.
Rheumatoid arthritis drug tofacitinib could be a blockbuster.
Pfizer Looks Fine Post-Tornado
Earnings statement gets jumbled up post-Lipitor, breakup.
Will You Get a Health Insurance Rebate?
Insurers may pay back more than $1 billion in premiums. What's your fair share?
Anemic Growth? Not From These Drugs.
Amgen overcomes substantial drops in its anemia franchise.
Here's One Way Huge Companies Aren't Too Big to Fail
Shareholders just delivered a major smackdown to Citigroup. Who's next?
Has Celgene Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
This Biotech Buys a Generic Lifeline
Amgen buys KAI Pharmaceuticals to replace Sensipar.
Is Molina Healthcare the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK